BARRETT M JAMES
Insider CIK 1219855 · ILIU 10% owner · SNSS 10% owner · CVT 10% owner · TRGT Director, 10% owner · VTAE 10% owner · PHAS 10% owner · ECOM 10% owner · WIFI 10% owner · FOLD Director, 10% owner · ADNC 10% owner · GLYC Director, 10% owner · INHX Director, 10% owner · DATA 10% owner · XOOM 10% owner · WDAY 10% owner · LQDA 10% owner · INWK 10% owner · SUPN Director, 10% owner · MM 10% owner · HIVE 10% owner · BOX 10% owner · MULE 10% owner · FIO 10% owner · HPTX 10% owner · TCON 10% owner · OPWR 10% owner · CRCM 10% owner · ECHO 10% owner · TRVN 10% owner · TRIV 10% owner · ARDX 10% owner · APPN 10% owner · MRSN 10% owner · PTI Director, 10% owner · CLVS Director, 10% owner · ROKA Director, 10% owner · OMTH Director, 10% owner · RARX 10% owner · GRPN 10% owner · TSRO 10% owner · MIRN 10% owner · CERC 10% owner · TNTR 10% owner · DERM 10% owner · EPZM 10% owner · LOXO Director, 10% owner · ZSAN Director, 10% owner · SENS Director, 10% owner · ADAP 10% owner · RYTM 10% owner · BE 10% owner · SURF 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SENS Senseonics Holdings, Inc. | A Award deriv | 2019-05-30 | 2019-06-03 | 86,930 | — | $0 | 86,930 | SEC↗ |
| SENS Senseonics Holdings, Inc. | A Award | 2019-01-02 | 2019-01-04 | 3,624 | $2.69 | $9.7K | 512,720 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 1,177 | $5.00 | $5.9K | 3,279,627 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 3,279,627 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 181,190 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 181,190 | $0.12 | $21.7K | 442,055 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 4,349 | $5.00 | $21.7K | 437,706 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 437,706 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 49,030 | $0.12 | $5.9K | 3,280,804 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 49,030 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 1,124,301 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 1,800,000 | $5.00 | $9.00M | 6,641,634 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 4,841,634 | — | $0 | 4,841,634 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-10-11 | 2018-10-15 | 14,770 | — | $0 | 14,770 | SEC↗ |
| SENS Senseonics Holdings, Inc. | A Award | 2018-10-01 | 2018-10-03 | 2,147 | $4.54 | $9.7K | 509,096 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-09-07 | 2018-09-10 | 3,000,000 | $1.67 | $5.01M | 82,978,668 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion deriv | 2018-07-30 | 2018-08-01 | 3,337,206 | — | $0 | 0 | SEC↗ |
| LQDA Liquidia Technologies Inc | J Other deriv | 2018-07-30 | 2018-08-01 | 40,702 | — | $0 | 40,702 | SEC↗ |
| LQDA Liquidia Technologies Inc | J Other deriv | 2018-07-30 | 2018-08-01 | 684,911 | — | $0 | 0 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion deriv | 2018-07-30 | 2018-08-01 | 16,502,833 | — | $0 | 0 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion deriv | 2018-07-30 | 2018-08-01 | 3,645,307 | — | $0 | 0 | SEC↗ |
| LQDA Liquidia Technologies Inc | P Buy | 2018-07-30 | 2018-08-01 | 545,455 | $11.00 | $6.00M | 2,484,870 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion | 2018-07-30 | 2018-08-01 | 980,715 | — | $0 | 1,939,415 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion | 2018-07-30 | 2018-08-01 | 515,547 | — | $0 | 526,667 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion | 2018-07-30 | 2018-08-01 | 432,033 | — | $0 | 958,700 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 4,527,868 | — | $0 | 4,527,868 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 4,527,868 | — | $0 | 0 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 346,239 | — | $0 | 7,729,641 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 346,239 | — | $0 | 0 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 650,631 | — | $0 | 7,383,402 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 650,631 | — | $0 | 0 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 125,989 | — | $0 | 6,732,771 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 125,989 | — | $0 | 0 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 395,815 | — | $0 | 6,606,782 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 395,815 | — | $0 | 0 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 620,155 | — | $0 | 6,210,967 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 620,155 | — | $0 | 0 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 1,062,944 | — | $0 | 5,590,812 | SEC↗ |
| BE Bloom Energy Corp | C Conversion deriv | 2018-07-27 | 2018-07-31 | 1,062,944 | — | $0 | 0 | SEC↗ |
| BE Bloom Energy Corp | P Buy | 2018-07-27 | 2018-07-31 | 1,333,333 | $15.00 | $20.00M | 1,333,333 | SEC↗ |
| SENS Senseonics Holdings, Inc. | A Award | 2018-07-02 | 2018-07-05 | 2,200 | $4.43 | $9.7K | 506,949 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | A Award deriv | 2018-06-15 | 2018-06-19 | 15,300 | — | $0 | 15,300 | SEC↗ |
| SENS Senseonics Holdings, Inc. | A Award deriv | 2018-05-30 | 2018-06-01 | 50,847 | — | $0 | 50,847 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2018-05-25 | 2018-05-30 | 416,667 | $4.00 | $1.67M | 9,169,210 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2018-05-18 | 2018-05-21 | 11,000 | — | $0 | 11,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | X Exercise deriv | 2018-05-10 | 2018-05-11 | 298,406 | — | $0 | 0 | SEC↗ |
| GLYC GLYCOMIMETICS INC | X Exercise deriv | 2018-05-10 | 2018-05-11 | 216,046 | — | $0 | 0 | SEC↗ |
| GLYC GLYCOMIMETICS INC | X Exercise | 2018-05-10 | 2018-05-11 | 298,406 | $0.33 | $98.5K | 5,001,197 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2018-05-10 | 2018-05-11 | 4,006 | $17.81 | $71.3K | 4,702,791 | SEC↗ |
| GLYC GLYCOMIMETICS INC | X Exercise | 2018-05-10 | 2018-05-11 | 216,046 | $0.33 | $71.3K | 4,706,797 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2018-05-10 | 2018-05-11 | 5,533 | $17.81 | $98.5K | 4,995,664 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 12,679,970 | SEC↗ |
| MULE MULESOFT, INC | U Tender | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion deriv | 2018-04-23 | 2018-04-23 | 6,995,000 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | P Buy | 2018-04-23 | 2018-04-23 | 133,333 | $15.00 | $2.00M | 3,312,877 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion | 2018-04-23 | 2018-04-23 | 3,179,544 | — | $0 | 3,179,544 | SEC↗ |
| SENS Senseonics Holdings, Inc. | A Award | 2018-04-02 | 2018-04-09 | 3,145 | $3.10 | $9.7K | 504,749 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-27 | 2018-03-28 | 6,000,000 | $1.92 | $11.52M | 79,978,672 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-26 | 2018-03-28 | 571,164 | $1.90 | $1.09M | 73,978,672 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-23 | 2018-03-23 | 294,090 | $1.95 | $573.5K | 73,407,508 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-22 | 2018-03-23 | 869,574 | $1.90 | $1.65M | 73,113,418 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-21 | 2018-03-23 | 104,844 | $1.81 | $189.8K | 72,243,844 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-06 | 2018-03-06 | 12,634 | $59.82 | $755.8K | 9,681,129 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-05 | 2018-03-06 | 30,321 | $58.28 | $1.77M | 9,649,647 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-05 | 2018-03-06 | 1,600 | $59.15 | $94.6K | 9,651,247 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-05 | 2018-03-06 | 17,248 | $59.76 | $1.03M | 9,668,495 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 4,080 | $56.66 | $231.2K | 9,601,467 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 17,859 | $57.34 | $1.02M | 9,619,326 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 6,399 | $55.01 | $352.0K | 9,597,387 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 26,304 | $54.32 | $1.43M | 9,590,988 | SEC↗ |
| TNTR Tintri, Inc. | E Expire deriv | 2018-02-26 | 2018-03-02 | 0 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | P Buy | 2018-02-16 | 2018-02-21 | 2,000,000 | $6.00 | $12.00M | 5,490,073 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2018-02-13 | 2018-02-15 | 2,724,202 | — | $0 | 0 | SEC↗ |
| APPN APPIAN CORP | C Conversion | 2018-02-13 | 2018-02-15 | 2,724,202 | — | $0 | 2,724,202 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 339 | — | $0 | 1,015 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 339 | — | $0 | 1,015 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 27,242 | — | $0 | 27,242 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 27,242 | — | $0 | 0 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 676 | — | $0 | 676 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 2,724,202 | — | $0 | 0 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 13,621 | — | $0 | 13,621 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 13,621 | — | $0 | 0 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 676 | — | $0 | 676 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2018-01-26 | 2018-01-26 | 410,000 | $9.75 | $4.00M | 4,228,940 | SEC↗ |
| SENS Senseonics Holdings, Inc. | A Award | 2018-01-02 | 2018-01-04 | 3,665 | $2.66 | $9.7K | 501,604 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2017-12-18 | 2017-12-19 | 2,000,000 | $5.00 | $10.00M | 5,554,610 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-11-27 | 2017-11-27 | 569,620 | — | $0 | 2,724,202 | SEC↗ |
| APPN APPIAN CORP | S Sale | 2017-11-27 | 2017-11-27 | 569,620 | $19.49 | $11.10M | 0 | SEC↗ |
| APPN APPIAN CORP | C Conversion | 2017-11-27 | 2017-11-27 | 569,620 | — | $0 | 569,620 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-11-20 | 2017-11-21 | 2,820,516 | — | $0 | 3,293,822 | SEC↗ |
| APPN APPIAN CORP | S Sale | 2017-11-20 | 2017-11-21 | 2,820,516 | $19.49 | $54.97M | 0 | SEC↗ |
| APPN APPIAN CORP | C Conversion | 2017-11-20 | 2017-11-21 | 2,820,516 | — | $0 | 2,820,516 | SEC↗ |
| CRCM Care.com Inc | J Other | 2017-11-06 | 2017-11-08 | 10,000 | — | $0 | 0 | SEC↗ |
| CRCM Care.com Inc | J Other | 2017-11-06 | 2017-11-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CRCM Care.com Inc | J Other | 2017-11-06 | 2017-11-08 | 252 | — | $0 | 252 | SEC↗ |
| CRCM Care.com Inc | J Other | 2017-11-06 | 2017-11-08 | 1,000,000 | — | $0 | 2,256,013 | SEC↗ |
| CRCM Care.com Inc | J Other | 2017-11-06 | 2017-11-08 | 252 | — | $0 | 252 | SEC↗ |
| SENS Senseonics Holdings, Inc. | A Award | 2017-10-12 | 2017-10-16 | 3,250 | — | $0 | 497,939 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 2,927,708 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 1,402,870 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | P Buy | 2017-10-10 | 2017-10-10 | 550,000 | $17.00 | $9.35M | 4,909,956 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 2,927,708 | — | $0 | 4,359,956 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 1,402,870 | — | $0 | 1,432,248 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2017-08-28 | 2017-08-30 | 3,394,439 | — | $0 | 3,818,940 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | A Award deriv | 2017-08-03 | 2017-08-07 | 63,663 | — | $0 | 63,663 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion deriv | 2017-07-03 | 2017-07-06 | 11,931,173 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion deriv | 2017-07-03 | 2017-07-06 | 18,001,419 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion deriv | 2017-07-03 | 2017-07-06 | 2,216,626 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2017-07-03 | 2017-07-06 | 1,000,000 | $15.00 | $15.00M | 8,140,138 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion | 2017-07-03 | 2017-07-06 | 7,140,138 | — | $0 | 7,140,138 | SEC↗ |
| ROKA Roka BioScience, Inc. | A Award deriv | 2017-06-28 | 2017-06-30 | 3,000 | — | $0 | 3,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2017-06-08 | 2017-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SENS Senseonics Holdings, Inc. | P Buy | 2017-06-01 | 2017-06-05 | 7,092,198 | $1.41 | $10.00M | 21,911,183 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-05-31 | 2017-05-31 | 6,114,338 | — | $0 | 6,114,338 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-05-31 | 2017-05-31 | 6,114,338 | — | $0 | 0 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2017-05-25 | 2017-05-30 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SENS Senseonics Holdings, Inc. | A Award deriv | 2017-05-24 | 2017-05-26 | 128,817 | — | $0 | 128,817 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2017-03-27 | 2017-03-28 | 12,870,000 | $0.70 | $9.01M | 72,139,000 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 2,064,048 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 8,000,038 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 605,668 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | J Other deriv | 2017-03-22 | 2017-03-22 | 12,679,970 | — | $0 | 12,679,970 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 1,689,436 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2017-03-22 | 2017-03-22 | 12,359,190 | — | $0 | 12,679,970 | SEC↗ |
| MULE MULESOFT, INC | J Other | 2017-03-22 | 2017-03-22 | 12,679,970 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-02-27 | 2017-03-01 | 1,139,890 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-02-27 | 2017-03-01 | 11,399 | — | $0 | 11,399 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-02-27 | 2017-03-01 | 287 | — | $0 | 861 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-02-27 | 2017-03-01 | 287 | — | $0 | 861 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-02-27 | 2017-03-01 | 11,399 | — | $0 | 0 | SEC↗ |
| ZSAN Zosano Pharma Corp | S Sale | 2017-02-13 | 2017-02-14 | 1,099,996 | $2.01 | $2.21M | 952,809 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2016-11-29 | 2016-11-29 | 869,565 | $5.75 | $5.00M | 2,758,039 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 4,689,657 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 12,447,605 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | X Exercise deriv | 2016-10-31 | 2016-10-31 | 80,658 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 4,362,472 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | P Buy | 2016-10-31 | 2016-10-31 | 338,462 | $13.00 | $4.40M | 3,490,073 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 623,210 | — | $0 | 3,151,611 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 669,951 | — | $0 | 2,528,401 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 1,778,227 | — | $0 | 1,858,450 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | X Exercise | 2016-10-31 | 2016-10-31 | 80,658 | $0.07 | $5.6K | 80,658 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2016-10-31 | 2016-10-31 | 435 | $13.00 | $5.7K | 80,223 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 5,714,286 | — | $0 | 5,714,286 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-30 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | S Sale | 2016-09-16 | 2016-09-20 | 7,471 | $0.75 | $5.6K | 2,052,805 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-09-14 | 2016-09-15 | 461,538 | $13.00 | $6.00M | 3,554,610 | SEC↗ |
| ZSAN Zosano Pharma Corp | S Sale | 2016-09-13 | 2016-09-15 | 10,000 | $0.74 | $7.4K | 2,060,276 | SEC↗ |
| ZSAN Zosano Pharma Corp | S Sale | 2016-08-29 | 2016-08-31 | 50,000 | $1.01 | $50.5K | 2,070,276 | SEC↗ |
| ZSAN Zosano Pharma Corp | S Sale | 2016-08-24 | 2016-08-26 | 1,200 | $1.21 | $1.5K | 2,120,276 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy deriv | 2016-07-29 | 2016-08-02 | 20,120,724 | — | $0 | 20,120,724 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy | 2016-07-29 | 2016-08-02 | 20,120,724 | $0.10 | $2.01M | 55,418,811 | SEC↗ |
| ZSAN Zosano Pharma Corp | S Sale | 2016-07-21 | 2016-07-21 | 8,989 | $1.33 | $12.0K | 2,121,476 | SEC↗ |
| ZSAN Zosano Pharma Corp | S Sale | 2016-07-20 | 2016-07-21 | 14,158 | $1.24 | $17.6K | 2,130,465 | SEC↗ |
| ZSAN Zosano Pharma Corp | S Sale | 2016-07-19 | 2016-07-21 | 534 | $1.17 | $625 | 2,144,623 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2016-07-18 | 2016-07-20 | 763,650 | $8.73 | $6.67M | 8,752,543 | SEC↗ |
| ZSAN Zosano Pharma Corp | S Sale | 2016-07-13 | 2016-07-15 | 13,382 | $1.20 | $16.1K | 2,145,157 | SEC↗ |
| ROKA Roka BioScience, Inc. | A Award deriv | 2016-06-22 | 2016-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OPWR OPOWER, INC. | U Tender | 2016-06-14 | 2016-06-14 | 8,989,766 | $10.30 | $92.59M | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2016-06-09 | 2016-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SENS Senseonics Holdings, Inc. | A Award deriv | 2016-05-24 | 2016-05-26 | 54,629 | — | $0 | 54,629 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2016-05-17 | 2016-05-19 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SENS Senseonics Holdings, Inc. | P Buy | 2016-03-23 | 2016-03-23 | 1,578,947 | $2.85 | $4.50M | 14,818,985 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2016-03-18 | 2016-03-18 | 710,429 | $35.19 | $25.00M | 9,564,684 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | G Gift | 2016-03-16 | 2016-03-24 | 18,000 | — | $0 | 97,355 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2016-03-01 | 2016-03-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | C Conversion deriv | 2016-02-17 | 2016-02-17 | 4,423,723 | — | $0 | 0 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | C Conversion deriv | 2016-02-17 | 2016-02-17 | 13,848,000 | — | $0 | 0 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | C Conversion | 2016-02-17 | 2016-02-17 | 2,192,748 | — | $0 | 2,192,748 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-02-17 | 2016-02-17 | 900,324 | $8.00 | $7.20M | 3,093,072 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | A Award deriv | 2016-02-10 | 2016-02-12 | 45,760 | — | $0 | 45,760 | SEC↗ |
| TRIV TriVascular Technologies, | D To issuer | 2016-02-03 | 2016-02-04 | 3,943,269 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2016-01-13 | 2016-01-14 | 500,000 | $10.00 | $5.00M | 7,988,893 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2016-01-12 | 2016-01-12 | 1,111,111 | $9.00 | $10.00M | 5,854,351 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-12-08 | 2015-12-08 | 70,913 | $14.75 | $1.05M | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-12-07 | 2015-12-08 | 71,067 | $14.38 | $1.02M | 70,913 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-12-04 | 2015-12-08 | 70,990 | $14.54 | $1.03M | 141,980 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-12-03 | 2015-12-03 | 41,426 | — | $0 | 115,355 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-12-03 | 2015-12-03 | 8,733 | — | $0 | 24,317 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-12-03 | 2015-12-03 | 11,980 | — | $0 | 33,360 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-12-03 | 2015-12-03 | 20,713 | — | $0 | 57,678 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-12-03 | 2015-12-03 | 212,970 | — | $0 | 212,970 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-12-03 | 2015-12-03 | 1,172,932 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-12-03 | 2015-12-03 | 1,172,932 | — | $0 | 1,172,932 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-12-03 | 2015-12-03 | 3,820,625 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2015-11-25 | 2015-11-30 | 7,457 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2015-11-25 | 2015-11-30 | 8,722 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-11-25 | 2015-11-30 | 16,179 | $16.35 | $264.5K | 73,929 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2015-11-25 | 2015-11-30 | 7,457 | $9.24 | $68.9K | 90,108 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2015-11-25 | 2015-11-30 | 8,722 | $7.90 | $68.9K | 82,651 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-11-18 | 2015-11-18 | 43,000 | $16.50 | $709.5K | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-11-17 | 2015-11-18 | 50,000 | $16.71 | $835.5K | 43,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | X Exercise deriv | 2015-11-16 | 2015-11-18 | 9,445 | $0.33 | $3.1K | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-11-16 | 2015-11-17 | 19,650 | $16.13 | $317.0K | 93,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | X Exercise | 2015-11-16 | 2015-11-18 | 9,445 | $0.33 | $3.1K | 4,491,203 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2015-11-16 | 2015-11-18 | 452 | $6.91 | $3.1K | 4,490,751 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-11-13 | 2015-11-17 | 100,000 | $16.26 | $1.63M | 112,650 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-11-11 | 2015-11-12 | 8,728 | — | $0 | 15,584 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-11-11 | 2015-11-12 | 3,820,625 | — | $0 | 3,820,625 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-11-11 | 2015-11-12 | 1,172,932 | — | $0 | 1,172,932 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-11-11 | 2015-11-12 | 1,172,932 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-11-11 | 2015-11-12 | 41,405 | — | $0 | 73,929 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-11-11 | 2015-11-12 | 20,703 | — | $0 | 36,965 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-11-11 | 2015-11-12 | 11,974 | — | $0 | 21,380 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-11-11 | 2015-11-12 | 212,650 | — | $0 | 212,650 | SEC↗ |
| CERC Cerecor Inc. | C Conversion deriv | 2015-10-20 | 2015-10-20 | 16,638,880 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | C Conversion | 2015-10-20 | 2015-10-20 | 594,245 | — | $0 | 594,245 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-06 | 857,142 | $7.00 | $6.00M | 2,971,517 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-06 | 31,650 | — | $0 | 2,114,375 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-06 | 257,516 | — | $0 | 1,499,166 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 1,241,650 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 2,082,725 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 1,241,650 | — | $0 | 1,241,650 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2015-07-28 | 2015-07-30 | 7,812 | — | $0 | 7,812 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2015-07-15 | 2015-08-11 | 11,000 | — | $0 | 11,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | J Other | 2015-07-01 | 2015-07-02 | 8,250 | — | $0 | 8,250 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | I Discretionary | 2015-07-01 | 2015-07-02 | 8,250 | — | $0 | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | J Other | 2015-07-01 | 2015-07-02 | 1,134 | — | $0 | 1,134 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | J Other | 2015-07-01 | 2015-07-02 | 825,000 | — | $0 | 1,786,564 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | J Other | 2015-07-01 | 2015-07-02 | 464 | — | $0 | 464 | SEC↗ |
| ROKA Roka BioScience, Inc. | A Award deriv | 2015-06-24 | 2015-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-06-17 | 2015-06-19 | 48,796 | $16.02 | $781.7K | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-06-17 | 2015-06-19 | 63,085 | $16.67 | $1.05M | 48,796 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-06-16 | 2015-06-17 | 55,105 | $16.85 | $928.5K | 111,881 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-06-15 | 2015-06-17 | 3,000,000 | — | $0 | 7,641,250 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-06-15 | 2015-06-17 | 16,262 | — | $0 | 16,262 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-06-15 | 2015-06-17 | 9,406 | — | $0 | 9,406 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-06-15 | 2015-06-17 | 6,856 | — | $0 | 6,856 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-06-15 | 2015-06-17 | 32,524 | — | $0 | 32,524 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-06-15 | 2015-06-17 | 921,000 | — | $0 | 921,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-06-15 | 2015-06-17 | 921,000 | — | $0 | 921,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-06-15 | 2015-06-17 | 166,986 | — | $0 | 166,986 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2015-06-11 | 2015-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy deriv | 2015-06-05 | 2015-06-09 | 560,748 | $0.13 | $72.9K | 560,748 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2015-06-05 | 2015-06-09 | 1,869,159 | $10.70 | $20.00M | 7,488,893 | SEC↗ |
| TSRO TESARO, Inc. | S Sale | 2015-06-02 | 2015-06-04 | 629 | $58.13 | $36.6K | 0 | SEC↗ |
| TSRO TESARO, Inc. | S Sale | 2015-06-02 | 2015-06-04 | 1,500 | $57.55 | $86.3K | 629 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-06-01 | 2015-06-02 | 2,129 | — | $0 | 2,129 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-06-01 | 2015-06-02 | 252 | — | $0 | 252 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-06-01 | 2015-06-02 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-06-01 | 2015-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-06-01 | 2015-06-02 | 1,000,000 | — | $0 | 8,854,255 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-06-01 | 2015-06-02 | 252 | — | $0 | 252 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-05-15 | 2015-05-15 | 1,924 | $92.57 | $178.1K | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-05-15 | 2015-05-15 | 500 | $91.86 | $45.9K | 1,924 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-15 | 287 | — | $0 | 574 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-15 | 11,399 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-15 | 11,399 | — | $0 | 11,399 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-15 | 1,139,891 | — | $0 | 1,139,890 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-15 | 2,424 | — | $0 | 2,424 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-15 | 287 | — | $0 | 574 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | U Tender | 2015-05-07 | 2015-05-11 | 2,384,221 | $46.00 | $109.67M | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2015-03-03 | 2015-03-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | C Conversion deriv | 2015-02-04 | 2015-02-05 | 5,373,396 | — | $0 | 0 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | C Conversion | 2015-02-04 | 2015-02-05 | 1,388,474 | — | $0 | 1,388,474 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2015-02-04 | 2015-02-05 | 500,000 | $10.00 | $5.00M | 1,888,474 | SEC↗ |
| ZSAN Zosano Pharma Corp | C Conversion deriv | 2015-01-30 | 2015-02-02 | 0 | — | $0 | 0 | SEC↗ |
| ZSAN Zosano Pharma Corp | C Conversion deriv | 2015-01-30 | 2015-02-02 | 0 | — | $0 | 0 | SEC↗ |
| ZSAN Zosano Pharma Corp | C Conversion deriv | 2015-01-30 | 2015-02-02 | 0 | — | $0 | 0 | SEC↗ |
| ZSAN Zosano Pharma Corp | P Buy | 2015-01-30 | 2015-02-02 | 23,457 | $11.00 | $258.0K | 2,158,539 | SEC↗ |
| ZSAN Zosano Pharma Corp | C Conversion | 2015-01-30 | 2015-02-02 | 341,201 | $9.35 | $3.19M | 2,135,082 | SEC↗ |
| BOX BOX INC | C Conversion deriv | 2015-01-28 | 2015-01-29 | 1,653,761 | — | $0 | 0 | SEC↗ |
| BOX BOX INC | J Other deriv | 2015-01-28 | 2015-01-29 | 2,091,457 | — | $0 | 2,091,457 | SEC↗ |
| BOX BOX INC | C Conversion deriv | 2015-01-28 | 2015-01-29 | 274,916 | — | $0 | 0 | SEC↗ |
| BOX BOX INC | C Conversion | 2015-01-28 | 2015-01-29 | 1,928,677 | — | $0 | 2,091,457 | SEC↗ |
| BOX BOX INC | J Other | 2015-01-28 | 2015-01-29 | 2,091,457 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | S Sale | 2014-12-26 | 2014-12-29 | 1,972 | $21.28 | $42.0K | 0 | SEC↗ |
| ARDX ARDELYX, INC. | S Sale | 2014-12-26 | 2014-12-29 | 296 | $21.54 | $6.4K | 0 | SEC↗ |
| ARDX ARDELYX, INC. | S Sale | 2014-12-26 | 2014-12-29 | 296 | $21.54 | $6.4K | 0 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy deriv | 2014-12-23 | 2014-12-29 | 19,868,965 | — | $0 | 19,868,965 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2014-12-23 | 2014-12-29 | 10,000 | — | $0 | 0 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy | 2014-12-23 | 2014-12-29 | 19,868,965 | $0.10 | $1.99M | 35,298,087 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2014-12-23 | 2014-12-29 | 296 | — | $0 | 296 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2014-12-23 | 2014-12-29 | 10,000 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2014-12-23 | 2014-12-29 | 1,972 | — | $0 | 1,972 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2014-12-23 | 2014-12-29 | 296 | — | $0 | 296 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-22 | 2014-12-22 | 55,994 | $8.01 | $448.5K | 3,569,210 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-19 | 2014-12-22 | 27,790 | $7.91 | $219.8K | 3,625,204 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-18 | 2014-12-18 | 52,998 | $7.90 | $418.7K | 3,652,994 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-17 | 2014-12-18 | 63,094 | $7.72 | $487.1K | 3,705,992 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-16 | 2014-12-18 | 27,233 | $7.76 | $211.3K | 3,769,086 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-15 | 2014-12-15 | 16,859 | $7.82 | $131.8K | 3,796,319 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-12 | 2014-12-15 | 56,420 | $7.93 | $447.4K | 3,813,178 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2014-12-12 | 2014-12-16 | 1,000,000 | — | $0 | 5,619,734 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-11 | 2014-12-15 | 53,182 | $7.92 | $421.2K | 3,869,598 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-12-10 | 2014-12-10 | 1,000,000 | $4.00 | $4.00M | 4,811,691 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-10 | 2014-12-10 | 31,220 | $7.87 | $245.7K | 3,922,780 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-09 | 2014-12-10 | 26,992 | $7.79 | $210.3K | 3,954,000 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-08 | 2014-12-10 | 21,448 | $7.71 | $165.4K | 3,980,992 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-05 | 2014-12-05 | 18,959 | $7.83 | $148.4K | 4,002,440 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-04 | 2014-12-05 | 38,061 | $7.83 | $298.0K | 4,021,399 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-03 | 2014-12-05 | 46,635 | $7.92 | $369.3K | 4,059,460 | SEC↗ |
| DATA Tableau Software Inc | C Conversion deriv | 2014-12-02 | 2014-12-04 | 1,250,000 | — | $0 | 1,964,192 | SEC↗ |
| WIFI BOINGO WIRELESS INC | S Sale | 2014-12-02 | 2014-12-02 | 61,569 | $7.90 | $486.4K | 4,106,095 | SEC↗ |
| DATA Tableau Software Inc | J Other | 2014-12-02 | 2014-12-04 | 69,572 | — | $0 | 69,572 | SEC↗ |
| DATA Tableau Software Inc | C Conversion | 2014-12-02 | 2014-12-04 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |